LeMaitre Vascular, Inc. (LMAT) Q2 2022 Earnings Results

Lemaitre Vascular Misses on EPS, Stock Up 1.54%

The earnings report indicates that Lemaitre Vascular faced some challenges with EPS falling short of expectations. However, the stock reacted positively, rising 1.54%, likely due to management's optimistic outlook for future growth and ongoing investments. Investors may be encouraged by the company's focus on product development and market expansion.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.29	N/A	-8.52%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding future opportunities. They emphasized their commitment to innovation and market expansion.

Management highlighted ongoing investments in product development.

They expressed confidence in long-term growth despite current challenges.

Lemaitre Vascular Misses on EPS, Stock Up 1.54%

Key numbers

Management commentary

LeMaitre Vascular, Inc.

More earnings this week

Lemaitre Vascular Misses on EPS, Stock Up 1.54%

Key numbers

Management commentary